Esraa Hassan Salih Elhaj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Esraa Hassan Salih Elhaj has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Khabab Abbasher Hussien Mohamed Ahmed
Faculty of Medicine University of Khartoum Khartoum Sudan
6 shared publications - Ghassan E. Mustafa Ahmed
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
2 shared publications - Mustafa Mohamed Ibrahim Ali
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
2 shared publications - Abbasher Hussien
Faculty of Medicine, University of Khartoum
1 shared publication Abdallah M. Abdallah
Faculty of Medicine University of Bahri Khartoum Sudan
1 shared publication- Ahmed Daffalla Mussaad Mohammed
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
1 shared publication
Latest Publications
- 1 October 2025
- Published by Springer Nature
- p. 2033-2055
Quality-of-Life Domains in Hemodialysis Patients: A Comprehensive Review
- 1 October 2025
- Published by Springer Nature
- p. 2033-2055
Quality-of-Life Domains in Hemodialysis Patients: A Comprehensive Review
- Open Access
- 18 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7390-7399
Neurological manifestations of COVID-19 and its vaccines: an updated comprehensive review with an insight into pathophysiology
The COVID-19 pandemic caused by SARS-CoV-2 has had a significant global impact on the respiratory system and multiple organ systems, including the nervous system. Neurological manifestations associated with COVID-19 infection and its vaccines have been increasingly recognized, ranging from problems with smell and taste to more severe conditions such as encephalitis, stroke, and Guillain–Barré syndrome. This narrative review critically evaluates the neurological manifestations of COVID-19 infection and its vaccines, providing insights into potential pathophysiological mechanisms. A comprehensive literature search was conducted, and data were retrieved from various databases. The prevalence, types, and severity of neurological symptoms in COVID-19 patients were discussed. The possible mechanisms of neurological injury in COVID-19 were explored, including direct viral invasion, hypoxic brain injury, immune-mediated damage, and cerebrovascular injury. Furthermore, the review addressed the neurological complications associated with COVID-19 vaccination. While severe vaccine-related adverse effects remain rare, understanding their occurrence is essential for risk assessment and public health interventions. In conclusion, COVID-19 can affect the nervous system in various ways, leading to various neurological symptoms. Further research is necessary to enhance our understanding of these manifestations and develop effective preventive and treatment strategies to manage this global health crisis.
- 18 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7390-7399
Open AccessNeurological manifestations of COVID-19 and its vaccines: an updated comprehensive review with an insight into pathophysiology
The COVID-19 pandemic caused by SARS-CoV-2 has had a significant global impact on the respiratory system and multiple organ systems, including the nervous system. Neurological manifestations associated with COVID-19 infection and its vaccines have been increasingly recognized, ranging from problems with smell and taste to more severe conditions such as encephalitis, stroke, and Guillain–Barré syndrome. This narrative review critically evaluates the neurological manifestations of COVID-19 infection and its vaccines, providing insights into potential pathophysiological mechanisms. A comprehensive literature search was conducted, and data were retrieved from various databases. The prevalence, types, and severity of neurological symptoms in COVID-19 patients were discussed. The possible mechanisms of neurological injury in COVID-19 were explored, including direct viral invasion, hypoxic brain injury, immune-mediated damage, and cerebrovascular injury. Furthermore, the review addressed the neurological complications associated with COVID-19 vaccination. While severe vaccine-related adverse effects remain rare, understanding their occurrence is essential for risk assessment and public health interventions. In conclusion, COVID-19 can affect the nervous system in various ways, leading to various neurological symptoms. Further research is necessary to enhance our understanding of these manifestations and develop effective preventive and treatment strategies to manage this global health crisis.
- 19 June 2024
- Published by Wiley in Respirology
- Vol. 29 (8) , 734-735
The challenges facing children with pulmonary tuberculosis—a catastrophe of civil war: Letter from Sudan
- 19 June 2024
- Published by Wiley in Respirology
- Vol. 29 (8) , 734-735
The challenges facing children with pulmonary tuberculosis—a catastrophe of civil war: Letter from Sudan
- Open Access
- 17 May 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (7) , 3808-3811
Tele-stroke: a strategy to improve acute stroke care in low- and middle-income countries
- 17 May 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (7) , 3808-3811
Open AccessTele-stroke: a strategy to improve acute stroke care in low- and middle-income countries
- 1 January 2024
- Published by Springer Nature
- p. 1-22
Quality-of-Life Domains in Hemodialysis Patients: A Comprehensive Review
- 1 January 2024
- Published by Springer Nature
- p. 1-22
Quality-of-Life Domains in Hemodialysis Patients: A Comprehensive Review
- 21 April 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (8) , 3685-3697
Clinical characteristics, complications, and predictors of outcome of hospitalized adult Sudanese patients with COVID‐19 and malaria coinfection in Sudan: A multicenter retrospective cross‐sectional study
Malaria and coronavirus disease 2019 (COVID‐19) share several characteristics that could lead to cross‐infection, particularly in malaria‐endemic areas. Early COVID‐19 symptoms might be misdiagnosed for malaria in clinical settings. Also, both diseases can cause fatal complications. So, laboratory testing for both diseases was recommended by the World Health Organization. To study the clinical characteristics and outcomes of Adult Sudanese patients with COVID‐19 and malaria coinfection. This retrospective cross‐sectional study was conducted from January 2021 to October 2021 in Wad Medani. Total coverage of all Sudanese patients above 18 years old with a confirmed diagnosis of coinfection with COVID‐19 and malaria was included, and data were collected using a data collection sheet. Data were analyzed using R software version 4.0.2. Data were described and presented as mean, standard deviation, and number (percentage). To find associated factors with in‐hospital outcome, χ 2 test, fisher exact test, and independent t test or Wilcoxon rank‐sum test were used. In this study, 156 participants were diagnosed with COVID‐19 and malaria coinfection. Most of them were between 60 and 70 years (30.8%), the majority were males (59%). Shortness of breath (76.3%) and acute respiratory distress syndrome (35.3%) were the most common symptom and complications among coinfected patients, respectively. Ground glass opacity ( n = 47/49, 95.9%) is the most common result for computed tomography scan. Atrial fibrillation was the most common abnormal electrocardiogram finding ( n = 6/62, 9.7%). Overall mortality among all participants was (63/156, 40.4%). High mortality rate was found among the coinfected patients. More attention is needed towards fighting COVID‐19 and malaria coinfection. There may be a link between malaria and COVID‐19.
- 21 April 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (8) , 3685-3697
Clinical characteristics, complications, and predictors of outcome of hospitalized adult Sudanese patients with COVID‐19 and malaria coinfection in Sudan: A multicenter retrospective cross‐sectional study
Malaria and coronavirus disease 2019 (COVID‐19) share several characteristics that could lead to cross‐infection, particularly in malaria‐endemic areas. Early COVID‐19 symptoms might be misdiagnosed for malaria in clinical settings. Also, both diseases can cause fatal complications. So, laboratory testing for both diseases was recommended by the World Health Organization. To study the clinical characteristics and outcomes of Adult Sudanese patients with COVID‐19 and malaria coinfection. This retrospective cross‐sectional study was conducted from January 2021 to October 2021 in Wad Medani. Total coverage of all Sudanese patients above 18 years old with a confirmed diagnosis of coinfection with COVID‐19 and malaria was included, and data were collected using a data collection sheet. Data were analyzed using R software version 4.0.2. Data were described and presented as mean, standard deviation, and number (percentage). To find associated factors with in‐hospital outcome, χ 2 test, fisher exact test, and independent t test or Wilcoxon rank‐sum test were used. In this study, 156 participants were diagnosed with COVID‐19 and malaria coinfection. Most of them were between 60 and 70 years (30.8%), the majority were males (59%). Shortness of breath (76.3%) and acute respiratory distress syndrome (35.3%) were the most common symptom and complications among coinfected patients, respectively. Ground glass opacity ( n = 47/49, 95.9%) is the most common result for computed tomography scan. Atrial fibrillation was the most common abnormal electrocardiogram finding ( n = 6/62, 9.7%). Overall mortality among all participants was (63/156, 40.4%). High mortality rate was found among the coinfected patients. More attention is needed towards fighting COVID‐19 and malaria coinfection. There may be a link between malaria and COVID‐19.